{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:11:28Z","timestamp":1790813488372,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejmech.2014.12.033","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T08:13:51Z","timestamp":1419063231000},"page":"64-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist \u2013 Neurokinin-1 antagonist peptidomimetics"],"prefix":"10.1016","volume":"92","author":[{"given":"Karel","family":"Guillemyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycia","family":"Kleczkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Dyniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Van der Poorten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Van den Eynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Keresztes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga N.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Rojewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Van Duppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Przewlocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7653-0516","authenticated-orcid":false,"given":"Jozef","family":"Vanden Broeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej W.","family":"Lipkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Tourw\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ballet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.12.033_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2013.03.039","article-title":"Opioids and their receptors: are we there yet?","volume":"76","author":"Pasternak","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.12.033_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.113.205344","article-title":"Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain","volume":"346","author":"Labuz","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.12.033_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(95)12022-V","article-title":"The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive","volume":"199","author":"Ossipov","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2014.12.033_bib4","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2014.12.033_bib5","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","article-title":"The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2014.12.033_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2950625","article-title":"Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors","volume":"295","author":"Chen","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2014.12.033_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2014.12.033_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3959(86)90169-7","article-title":"Chronic pain and the family: a review","volume":"26","author":"Payne","year":"1986","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2014.12.033_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(24)36427-4","article-title":"Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat","volume":"280","author":"Chaplan","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.12.033_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pain.2005.04.014","article-title":"Role of NK-1 neurotransmission in opioid-induced hyperalgesia","volume":"116","author":"King","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2014.12.033_bib11","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1021\/jm100157m","article-title":"Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines","volume":"53","author":"Yamamoto","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib12","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2174\/092986712801215883","article-title":"Designed multiple ligands: basic research vs clinical outcomes","volume":"19","author":"Costantino","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib13","series-title":"Design of Multitarget Ligands. In Lead Generation Approaches in Drug Discovery","first-page":"141","author":"Morphy","year":"2010"},{"key":"10.1016\/j.ejmech.2014.12.033_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1568026043451663","article-title":"New trends in the development of opioid peptide analogues as advanced remedies for pain relief","volume":"4","author":"Gentilucci","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib15","first-page":"585","article-title":"Cooperative reinforcement of opioid pharmacophores","volume":"39","author":"Lipkowski","year":"1987","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.ejmech.2014.12.033_bib16","series-title":"B-Casomorphins and Related Peptides: Recent Developments","first-page":"113","article-title":"Biological activities of a peptide containing both casomorphin-like and substance P antagonist structural characteristics","author":"Lipkowski","year":"1994"},{"key":"10.1016\/j.ejmech.2014.12.033_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2004.02.023","article-title":"Spinal antinociceptive effects of AA501, a novel chimeric peptide with opioid receptor agonist and tachykinin receptor antagonist moieties","volume":"488","author":"Bonney","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib18","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1073\/pnas.130181897","article-title":"A\u00a0substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic","volume":"97","author":"Foran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2014.12.033_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/jm070332f","article-title":"A\u00a0structure\u2013activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are \u03b4\/\u03bc opioid receptor agonists and neurokinin 1 receptor antagonists","volume":"51","author":"Yamamoto","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib20","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1021\/jm061369n","article-title":"Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for \u03b4\/\u03bc opioid receptor agonists and neurokinin-1 receptor antagonists","volume":"50","author":"Yamamoto","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1351\/pac199668040875","article-title":"Discovery of neurokinin antagonists","volume":"68","author":"Takaya","year":"1996","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1139\/y97-069","article-title":"Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs","volume":"75","author":"Longmore","year":"1997","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.ejmech.2014.12.033_bib23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(24)39091-3","article-title":"Evaluation of selective NK1 receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain","volume":"294","author":"Gonzalez","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.12.033_bib24","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/jm1016285","article-title":"Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist","volume":"54","author":"Ballet","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0223-5234(00)01171-5","article-title":"Synthesis and in\u00a0vitro opioid activity profiles of DALDA analogues","volume":"35","author":"Schiller","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib26","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1021\/jm0491795","article-title":"A\u00a0new structural motif for \u03bc-opioid antagonists","volume":"48","author":"Van den Eynde","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bmcl.2008.11.051","article-title":"Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold","volume":"19","author":"Ballet","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.12.033_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/psc.827","article-title":"Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus","volume":"13","author":"Ballet","year":"2007","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.ejmech.2014.12.033_bib29","doi-asserted-by":"crossref","first-page":"4,","DOI":"10.1186\/1756-6606-5-4","article-title":"In\u00a0vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist \u2013 neurokinin 1 receptor antagonist chimera","volume":"5","author":"Guillemyn","year":"2012","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejmech.2014.12.033_bib30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.2010.00824.x","article-title":"Spinal or systemic TY005, a peptidic opioid agonist\/neurokinin 1 antagonist, attenuates pain with reduced tolerance","volume":"161","author":"Largent-Milnes","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1399-3011.2005.00291.x","article-title":"Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using 4-amino-2-benzazepin-3-one scaffold","volume":"66","author":"Ballet","year":"2005","journal-title":"J.\u00a0Pept. Res."},{"key":"10.1016\/j.ejmech.2014.12.033_bib32","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1016\/S0040-4020(03)00583-0","article-title":"A\u00a0versatile synthesis of 2-substituted 4-amino-1,2,4,5-tetrahydro-2-benzazepine-3-ones","volume":"59","author":"Van Rompaey","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.12.033_bib33","unstructured":"Mondini, S., Dall Avo, M., Guerrato, A. Process for the preparation of 3,5-bistrifluoromethyl-N-methylbenzylamine. WO2007107818 A2, 2007."},{"key":"10.1016\/j.ejmech.2014.12.033_bib34","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1248\/cpb.39.2316","article-title":"Studies on analgesic oligopeptides. VII. Solid phase synthesis and biological properties of Tyr-D-Arg-Phe-\u00df-Ala-NH2 and its fluorinated aromatic amino acid derivatives","volume":"39","author":"Sasaki","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2014.12.033_bib35","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj080114","article-title":"Opioid ligands with mixed mu\/delta opioid receptor interactions: an emerging approach to novel analgesics","volume":"8","author":"Ananthan","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.ejmech.2014.12.033_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(25)20227-0","article-title":"Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice","volume":"258","author":"Abdelhamid","year":"1991","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.12.033_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/bja\/aep129","article-title":"Simultaneous targeting of multiple opioid receptors: a strategy to improve side- effect profile","volume":"103","author":"Dietis","year":"2009","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejmech.2014.12.033_bib38","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1021\/jm9700171","article-title":"Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the neurokinin-1 receptor","volume":"41","author":"Takeuchi","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib39","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1021\/jm3008079","article-title":"Variation of the net charge, lipophilicity, and side chain flexibility in Dmt1-DALDA: effect on opioid activity and biodistribution","volume":"55","author":"Novoa","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib40","first-page":"189","article-title":"pA2, a new scale for the measurement of drug antagonism","volume":"2","author":"Schild","year":"1947","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(95)00554-X","article-title":"Attenuation of morphine tolerance and dependence with the highly selective \u03b4-opioid receptor antagonist TIPP[\u03c8]","volume":"286","author":"Fundytus","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib42","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1021\/jm980724+","article-title":"The opioid \u03bc agonist\/\u03b4 antagonist DIPP-NH2[\u03a8] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats","volume":"42","author":"Schiller","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0024-3205(94)00494-3","article-title":"Spinal co-administration of peptide substance P antagonist potentiates antinociceptive effect of opioid peptide","volume":"54","author":"Misterek","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2014.12.033_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0304-3959(01)00410-9","article-title":"Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist","volume":"95","author":"Cahill","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2014.12.033_bib45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0028-3908(98)00125-7","article-title":"Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats","volume":"37","author":"Cumberbatch","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.12.033_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002826-200101000-00004","article-title":"Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy","volume":"24","author":"Goldstein","year":"2001","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ejpain.2005.08.001","article-title":"The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: a randomised, controlled trial","volume":"10","author":"Sindrup","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejmech.2014.12.033_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.regpep.2005.05.006","article-title":"Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay","volume":"131","author":"Janecka","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejmech.2014.12.033_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1476-5381.1997.tb06792.x","article-title":"Some quantitative uses of drug antagonists","volume":"120","author":"Arunlakshana","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib50","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.ejmech.2014.12.033_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1476-5381.1957.tb01373.x","article-title":"The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum","volume":"12","author":"Paton","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejmech.2014.12.033_bib52","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/jm00354a008","article-title":"Synthesis and pharmacological characterization in\u00a0vitro of cyclic enkephalin analogues: effect of the conformational constraints on opioid receptor selectivity","volume":"25","author":"DiMaio","year":"1982","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(79)90334-0","article-title":"Opioid activities of fragments of \u03b2-endorphin and of its leucine65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin","volume":"58","author":"Waterfield","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jcc.540110405","article-title":"Macromodel \u2013 an integrated software system for modeling organic and bioorganic molecules using molecular mechanics","volume":"11","author":"Mohamadi","year":"1990","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2014.12.033_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)03823-6","article-title":"A\u00a0method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.12.033_bib56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuropharm.2013.08.031","article-title":"Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats","volume":"75","author":"Makuch","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.12.033_bib57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.01.013","article-title":"Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain","volume":"560","author":"Mika","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.12.033_bib58","series-title":"International Association for the Study of Pain","article-title":"Ethical guidelines for pain research in humans","author":"Zimmermann","year":"1983"},{"key":"10.1016\/j.ejmech.2014.12.033_bib59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejmech.2014.12.033_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A\u00a0peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414011428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414011428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:39:09Z","timestamp":1747240749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414011428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":60,"alternative-id":["S0223523414011428"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.12.033","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist \u2013 Neurokinin-1 antagonist peptidomimetics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}